News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
643,950 Results
Type
Article (61358)
Company Profile (181)
Press Release (582411)
Multimedia
Podcasts (101)
Webinars (12)
Section
Business (181718)
Career Advice (2075)
Deals (28570)
Drug Delivery (119)
Drug Development (68202)
Employer Resources (172)
FDA (14658)
Job Trends (14039)
News (300468)
Policy (29568)
Tag
Academia (2957)
Academic (2)
Accelerated approval (4)
Adcomms (23)
Allergies (77)
Alliances (47518)
ALS (83)
Alzheimer's disease (1339)
Antibody-drug conjugate (ADC) (119)
Approvals (14670)
Artificial intelligence (277)
Autoimmune disease (20)
Automation (16)
Bankruptcy (259)
Best Places to Work (11409)
BIOSECURE Act (17)
Biosimilars (104)
Biotechnology (112)
Bladder cancer (74)
Brain cancer (22)
Breast cancer (258)
Cancer (2015)
Cardiovascular disease (170)
Career advice (1783)
Career pathing (33)
CAR-T (126)
Cell therapy (388)
Cervical cancer (19)
Clinical research (54820)
Collaboration (806)
Compensation (214)
Complete response letters (15)
COVID-19 (2677)
CRISPR (42)
C-suite (249)
Cystic fibrosis (87)
Data (2028)
Decentralized trials (2)
Denatured (36)
Depression (44)
Diabetes (252)
Diagnostics (6313)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (117)
Drug pricing (113)
Drug shortages (24)
Duchenne muscular dystrophy (91)
Earnings (69555)
Editorial (39)
Employer branding (25)
Employer resources (147)
Events (105793)
Executive appointments (735)
FDA (15801)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (739)
Gene editing (95)
Generative AI (28)
Gene therapy (294)
GLP-1 (710)
Government (4729)
Grass and pollen (5)
Guidances (60)
Healthcare (18747)
Huntington's disease (19)
IgA nephropathy (27)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2828)
Inflammatory bowel disease (137)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (84)
Interviews (341)
IPO (12663)
IRA (43)
Job creations (3071)
Job search strategy (1528)
Kidney cancer (8)
Labor market (36)
Layoffs (370)
Leadership (19)
Legal (6835)
Liver cancer (66)
Lung cancer (291)
Lymphoma (133)
Machine learning (7)
Management (56)
Manufacturing (283)
MASH (64)
Medical device (12391)
Medtech (12395)
Mergers & acquisitions (16408)
Metabolic disorders (658)
Multiple sclerosis (74)
NASH (17)
Neurodegenerative disease (85)
Neuropsychiatric disorders (21)
Neuroscience (1842)
NextGen: Class of 2025 (6612)
Non-profit (4761)
Now hiring (38)
Obesity (351)
Opinion (218)
Ovarian cancer (65)
Pain (80)
Pancreatic cancer (63)
Parkinson's disease (141)
Partnered (20)
Patents (206)
Patient recruitment (93)
Peanut (42)
People (54614)
Pharmaceutical (48)
Pharmacy benefit managers (18)
Phase I (17286)
Phase II (23330)
Phase III (18394)
Pipeline (1125)
Policy (147)
Postmarket research (2616)
Preclinical (7493)
Press Release (66)
Prostate cancer (106)
Psychedelics (32)
Radiopharmaceuticals (235)
Rare diseases (351)
Real estate (5243)
Recruiting (65)
Regulatory (19914)
Reports (51)
Research institute (2483)
Resumes & cover letters (299)
Rett syndrome (4)
RNA editing (5)
RSV (43)
Schizophrenia (66)
Series A (132)
Series B (83)
Service/supplier (11)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (130)
Sponsored (30)
Startups (3362)
State (1)
Stomach cancer (12)
Supply chain (64)
Tariffs (32)
The Weekly (63)
Vaccines (724)
Venture capitalists (39)
Weight loss (236)
Women's health (36)
Worklife (19)
Date
Today (181)
Last 7 days (818)
Last 30 days (2426)
Last 365 days (30322)
2025 (10038)
2024 (32386)
2023 (36702)
2022 (47288)
2021 (51636)
2020 (50834)
2019 (45119)
2018 (34019)
2017 (29575)
2016 (30333)
2015 (34674)
2014 (28427)
2013 (25552)
2012 (26608)
2011 (26409)
2010 (24865)
Location
Africa (935)
Alabama (53)
Alaska (7)
Arizona (191)
Arkansas (13)
Asia (37001)
Australia (6700)
California (5361)
Canada (1842)
China (466)
Colorado (262)
Connecticut (272)
Delaware (137)
Europe (86247)
Florida (833)
Georgia (205)
Hawaii (1)
Idaho (52)
Illinois (519)
India (29)
Indiana (311)
Iowa (9)
Japan (155)
Kansas (95)
Kentucky (23)
Louisiana (12)
Maine (70)
Maryland (839)
Massachusetts (4100)
Michigan (233)
Minnesota (349)
Mississippi (2)
Missouri (85)
Montana (22)
Nebraska (24)
Nevada (61)
New Hampshire (60)
New Jersey (1641)
New Mexico (26)
New York (1605)
North Carolina (947)
North Dakota (9)
Northern California (2359)
Ohio (187)
Oklahoma (15)
Oregon (35)
Pennsylvania (1225)
Puerto Rico (10)
Rhode Island (32)
South America (1217)
South Carolina (21)
South Dakota (1)
Southern California (2008)
Tennessee (100)
Texas (773)
United States (21097)
Utah (183)
Virginia (127)
Washington D.C. (65)
Washington State (517)
West Virginia (3)
Wisconsin (60)
643,950 Results for "oregon health and science university ohsu".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Breakthrough T1D Awards $2.8 Million in Funding to Expand Center of Excellence at University of Michigan and Oregon Health & Science University to Accelerate Type 1 Diabetes Research
April 24, 2025
·
5 min read
Oregon Health & Science University (OHSU) to utilize RayStation technology for radiation therapy planning
RaySearch Laboratories AB announces that Oregon Health & Science University in the USA has placed an order for the treatment planning system RayStation®*.
October 31, 2023
·
1 min read
Business
Skanska signs additional contract to expand hospital in Portland, Oregon, USA, for USD 200M, about SEK 2.1 billion
Skanska has signed an additional contract with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA.
December 22, 2023
·
1 min read
Biotech Beach
Biological Dynamics and Oregon Health & Science University Collaborate on Early-Stage Pancreatic Cancer Detection Study
Biological Dynamics, Inc., a company developing and commercializing its exosome-isolation ExoVerita™ platform for early disease diagnostics and other applications, announced its collaboration with the Brenden-Colson Center for Pancreatic Care at Oregon Health & Science University to study its ExoVita™ Pancreas assay.
March 1, 2023
·
3 min read
Business
Castle Biosciences Announces Support for OHSU’s War on Melanoma™
Oregon Health & Science University (OHSU) launched the War on Melanoma to eliminate melanoma as a cause of death.
June 20, 2022
·
3 min read
Press Releases
Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma
April 29, 2025
·
8 min read
Regulatory
Senate Democrats Demand Return of Fired CDC Staff:
Reuters
Democratic senators from Georgia, Oregon, Maryland and New Mexico called the Trump administration’s decision to terminate hundreds of CDC staffers reckless and unfair.
March 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Paige and NHS Wales Launch PanCancer Pilot to Triage Cases with AI at Betsi Cadwaladr University Health Board
April 24, 2025
·
3 min read
Press Releases
InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities
March 19, 2025
·
4 min read
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
1 of 64,395
Next
